Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from SNPs

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Cathie Wood Just Bought the Dip in Synopsys Stock. Should You?

Cathie Wood snapped up Synopsys shares after their biggest drop. Should investors follow her lead?

Barchart

How to Buy the Dip in Synopsys Stock with a 2:1 Reward/Risk Ratio

An option collar lets you bet on a rebound in this beaten-down tech stock with limited risk.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Of The Day: Is Synopsys Setting Up For A Recovery?

Shares of Synopsys, Inc. (NASDAQ:SNPS) are rebounding on Thursday. The stock was crushed on Wednesday, dropping by more than 35% after posting earnings, but there is a good chance the rebound continues.

Benzinga

Synopsys Analysts Flag Restructuring Needs, China Headwinds After Q3 Miss

Tech giants grapple with volatile market shifts as geopolitical tensions and competitive pressures reshape the semiconductor landscape. Shares of Synopsys Inc (NASDAQ:SNPS) tanked in early trading on Wednesday, after the company reported downbeat fiscal third-quarter results.

Benzinga

These Analysts Slash Their Forecasts On Synopsys Following Downbeat Q3 Results

Synopsys, Inc. (NASDAQ:SNPS) posted weaker-than-expected results for its third quarter after Tuesday’s closing bell.

Benzinga

Synopsys Q3 FY2025 Earnings Call Transcript

Synopsys, Inc. (NASDAQ:SNPS) released its third-quarter results after Tuesday’s closing bell.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Synopsys Stock Drops After Disappointing Q3 Earnings

Synopsys, Inc. (NASDAQ:SNPS) released its third-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter.

Benzinga

Top Wall Street Forecasters Revamp Synopsys Expectations Ahead Of Q3 Earnings

Synopsys, Inc. (NASDAQ:SNPS) will release earnings results for the third quarter fiscal year 2025 after the closing bell on Tuesday, Sept. 9.

Benzinga

Is Synopsys Stock Outperforming the Dow?

Synopsys' stock prices have had a notable surge in recent months and outperformed the Dow. Moreover, analysts remain strongly bullish on the stock’s longer-term prospects.

Barchart

Synopsys Stock Outlook: Is Wall Street Bullish or Bearish?

Although Synopsys has lagged the broader market over the past year, Wall Street analysts maintain a highly bullish stance on the company’s long-term growth trajectory and market leadership.

Barchart

Synopsys' Ansys Taps Nvidia Omniverse To Accelerate AI-Driven Engineering

Ansys, a Synopsys (NASDAQ:SNPS) company, and Nvidia (NASDAQ:NVDA) on Tuesday signed an agreement to license, sell, and support Omniverse technology within Ansys simulation solutions.

Benzinga

What You Need To Know Ahead of Synopsys' Earnings Release

Synopsys is expected to announce its third-quarter results later in August, and analysts expect solid growth in earnings.

Barchart

Synopsys Pops as Chip Export Restrictions Lift. Should You Buy SNPS Stock Now?

Synopsys shares gained after the White House lifted restrictions on export of chip-design software to China. Berenberg analysts believe SNPS shares could hit $600 in the coming months.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

3 AI Infrastructure Stocks With Strong Growth, Not Hype

Here are 3 AI stocks offering value and growth, backed by strong fundamentals and critical roles in the AI stack as investors seek alternatives to high-flyers

Barchart

Is Synopsys Stock Underperforming the Nasdaq?

Despite Synopsys' underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Synopsys Stock Will Climb or Sink?

Despite Synopsys’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

What to Expect From Synopsys’ Next Quarterly Earnings Report

Synopsys is expected to announce its second-quarter results by the end of May, and analysts expect a double-digit growth in earnings.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Synopsys Stock Underperforming the S&P 500?

Synopsys has observed a significant decline in revenues, earnings, and cash flows, yet analysts remain strongly bullish on the stock’s prospects.

Evening Standard

Starmer accuses Farage of ‘fawning’ over Putin as Reform MPs face ‘poodles’ jibe

Reform UK MP Lee Anderson also hit back over criticism of his party colleagues during a war of words with the SNP’s Stephen Flynn.

Barchart

Is Wall Street Bullish or Bearish on Synopsys Stock?

Although Synopsys has lagged the broader market this year, Wall Street analysts maintain strong confidence in its future growth potential.

Barchart

What to Expect From Synopsys' Q1 2025 Earnings Report

Synopsys is all set to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit decrease.

Barchart

2 AI Stocks That Could Beat the S&P 500 in 2025, According to Analysts

As the S&P 500’s momentum is projected to cool in 2025, analysts have set their sights on two AI stocks primed to outpace broader market returns.

Barchart

2 AI Stocks Goldman Sachs Believes Could 4X the S&P 500 in 2025

Analysts think that these two tech-centric names are trading at sizeable discounts headed into the new year.

MarketBeat

MarketBeat Week in Review – 12/9 - 12/13

Equities had their worst-performing week since October on inflation and interest rate concerns, but the market trend is still likely to be higher in 2025.

1 2 3

People

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.